Tag: Rs 325 crore
-
Aurobindo Pharma to Acquire Khandelwal Laboratories’ Non-Oncology Prescription Business for Rs 325 Crore
Overview of the Deal In a strategic move to expand its domestic prescription portfolio, Aurobindo Pharma has agreed to acquire the non-oncology prescription business of Mumbai-based Khandelwal Laboratories Pvt Ltd. The transaction is structured as a going-concern slump sale for a cash consideration of Rs 325 crore. The deal underscores the growing importance of consolidating…
-
Aurobindo Pharma Buys Khandelwal Laboratories’ Non-Oncology Prescription Business for Rs 325 Crore
Aurobindo Pharma Expands with Rs 325 Crore Acquisition of Khandelwal Laboratories’ Non-Oncology Prescription Business In a strategic move to strengthen its domestic portfolio, Aurobindo Pharma has agreed to acquire the non-oncology prescription business of Mumbai-based Khandelwal Laboratories Pvt Ltd on a going concern, slump sale basis for Rs 325 crore. The deal, aimed at bolstering…